The reduced USP9X and MCL1 levels were recently found to block BCR-ABL kinase signaling, taking chronic myelogenous leukemia cells to apoptosis [45]. The gene discussed is MCL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.